Kelin Ao (克林澳)克林澳

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

桂哌齐特是一种在国家药监局注册认定的药品。标注生产企业为北京四环制药有限公司。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:北京四环制药有限公司Chinese legal name: 北京四环制药有限公司、北京四环制药有限公司Chinese legal name: 北京四环制药有限公司、北京四环制药有限公司Chinese legal name: 北京四环制药有限公司。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 克林澳) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 北京四环制药有限公司.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 北京四环制药有限公司Chinese legal name: 北京四环制药有限公司, 北京四环制药有限公司Chinese legal name: 北京四环制药有限公司, 北京四环制药有限公司Chinese legal name: 北京四环制药有限公司.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 克林澳Recorded Chinese name: 克林澳
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 2ml*4支2 mL × 4 units

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 北京四环制药有限公司Chinese legal name: 北京四环制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20020125

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20020125

Manufacturer

Chinese legal name: 北京四环制药有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

2 mL × 4 units

中文说明书原文Original Chinese source label

批准文号

国药准字H20020125

生产企业

北京四环制药有限公司(国产)

适应症

1、脑血管疾病:脑动脉硬化,一过性脑缺血发作,脑血栓形成,脑栓塞,脑出血后遗症和脑外伤后遗症。2、心血管疾病:冠心病、心绞痛,如用于治疗心肌梗塞,应配合有关药物综合治疗。3、外周血管疾病:下肢动脉粥样硬化病,血栓闭塞性脉管炎,动脉炎、雷诺氏病等。

用法用量

一次1支,溶于500ml10%的葡萄糖或生理盐水中,静脉滴注,速度为100ml/h;一日1次。

不良反应

1、血液

禁忌

1、脑内出血后止血不完全者(止血困难的人)。 2、白血球减少者。 服用本品造成白血球减少史的患者及对本品过敏的患者禁用。

注意事项

1、服本药过程中要定期进行血液学检查。

贮藏

遮光、密闭保存。

规格

2ml*4支

证据Evidence

  • 批准文号: 国药准字H20020125
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.